Summary
COVID-19 pandemic has created opportunities for several industries: from e-learning and online gaming to sanitiser manufacturers and food staples industry.
The pandemic has generated prospects for the healthcare industry as well with bi...

Summary
COVID-19 pandemic is being considered as the Great Virus Crisis (GVC), having taken many lives and no proven vaccine or treatment yet.
Several companies across the globe are in a race to develop a treatment or a vaccine for the disease....

Summary
Imugene's preclinical research associated with mimotope vaccines targeting immune checkpoint inhibitors published in 'Frontiers in Immunology' journal.
Research discovered that mimotope peptides when included in Imugene's exclusive immu...

Summary
Prescient obtains two key licenses from world immunotherapy leader, University of Pennsylvania and Oxford University to create a revolutionary cancer therapy platform called “OmniCAR”.
OmniCAR platform would allow extraordin...

Marking a step forward, clinical-stage drug development company Noxopharm (ASX:NOX) has lodged a pre-IND (Investigational New Drug) submission with the U.S. Food and Drug Administration (FDA) for a Veyonda® clinical trial in COVID-19 (SARS-C...

The oncology therapeutic area is still looking for a breakthrough treatment that will establish itself as a go-to-treatment for treating malignancies. Making its way through, a novel cancer immunotherapy treatment has surfaced that provides relativel...

The Japanese Patent Office has accepted Anagrelide cancer patent application, and the patent would now proceed to grant, notified SUDA Pharmaceuticals Ltd (ASX:SUD) in its latest update. The patent “Use of Anagrelide for Treating Cancer” ...

With over 4.6 million people infected by the coronavirus across the world, and more than 312k people dead, the necessity for a vaccine against COVID-19 becomes more urgent by the day. According to WHO, coronavirus might become an endemic vi...